Skip to content
DataLookout
Menu

NCT06289621

Brief Transdiagnostic Treatment for Anxiety Disorders and Post-traumatic Stress Disorder (PTSD) in South Africa

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 2 words Show 6 more changesShow less
    • Enrollment closed, study ongoing
    • Primary completion date changed from estimate of Jul 31, 2026 to Oct 9, 2026
    • Study completion pushed from Dec 31, 2026 to Jun 30, 2027
    • Secondary endpoints: details revised at 4 of 4 entries
    • Site details revised
    • Publications: details revised at 3 of 3 entries
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 1, 2024 to May 8, 2024
    v3
  3. Notable Lead sponsor: Harvard Medical School (HMS and HSDM) to Massachusetts General Hospital
    • Collaborators revised (3)
    • Study description shortened, about 4 words
    • Study title shortened, about 3 words
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Structured Clinical Interview for the DSM-5 (SCID-5)
Timeframe: pre-treatment, post-treatment (immediately after the last treatment session), and 3-month follow-up
Clinician-Administered PTSD Scale for the DSM-5 (CAPS)
Timeframe: pre-treatment, post-treatment (immediately after the last treatment session), and 3-month follow-up
Work Social Adjustment Scale (WSAS)
Timeframe: pre-treatment, post-treatment (immediately after the last treatment session), and 3-month follow-up
General Anxiety Disorder-7 (GAD-7)
Timeframe: pre-treatment, immediately after the last treatment session, and 3-month follow-up
Beck Anxiety Inventory (BAI)
Timeframe: pre-treatment, post-treatment (immediately after the last treatment session), and 3-month follow-up
Safety Aid Scale (SAS)
Timeframe: pre-treatment, post-treatment (immediately after the last treatment session), and 3-month follow-up

Secondary (4)

Post-traumatic Disorder Checklist (PCL-5 PTSD Checklist (PCL-5)
Patient Health Questionnaire - 9 (PHQ-9)
Beck Depression Inventory (BDI)
Anxiety Sensitivity Index -3

Arms and interventions

Anxiety Disorders and Post-traumatic Stress Disorder (PTSD) Transdiagnostic Treatment ( FSET)Experimental

The anxiety disorders and post-traumatic stress disorder (PTSD) transdiagnostic treatment (FSET) is brief, 5-session, cognitive-behavioral intervention designed to treat symptoms associated with anxiety disorders and PTSD. The treatment is administered by lay providers (e.g., nurses) in primary care clinics in South Africa.

Enhanced Standard Care GroupOther

The enhanced standard care group is the condition. Those in the enhanced standard care control group will receive standard care plus referrals. Upon completion of the study, they will be offered the anxiety disorder and post-traumatic stress disorder treatment (FSET).

Behavioral: False Safety Behavioral Elimination Treatment (FSET), Enhanced Standard Care

Sites

1 site in 1 country

  • Stellenbosch UniversityCape Town, South Africa